Sign Up to like & get
recommendations!
0
Published in 2019 at "Biomaterials"
DOI: 10.1016/j.biomaterials.2019.119469
Abstract: Checkpoint inhibitors, such as anti-PD-1/PD-L1 antibodies, have been proven as a promising type of immunotherapy in a number of cancers, but the relatively low response rates limit their scope of clinical application. Here, we report…
read more here.
Keywords:
photodynamic therapy;
chemo;
chemo photodynamic;
cascade chemo ... See more keywords